Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
lanthanum polystyrene sulfonate powder
/
Liaoning Grand Nuokang Biopharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|
|||||||||
lanthanum polystyrene sulfonate powder
/
Liaoning Grand Nuokang Biopharma
Trial completion date, Trial primary completion date:
To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder
(clinicaltrials.gov) - Jun 7, 2021
P1/2
, N=48, Recruiting,
Sponsor: Liaoning Grand Nuokang Biopharmaceutical Co., Ltd.
Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Jun 2022
||
||||||||
lanthanum polystyrene sulfonate powder
/
Liaoning Grand Nuokang Biopharma
Enrollment open, Trial initiation date:
To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder
(clinicaltrials.gov) - Oct 28, 2020
P1/2
, N=48, Recruiting,
Sponsor: Liaoning Grand Nuokang Biopharmaceutical Co., Ltd.
Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Jun 2022 Not yet recruiting --> Recruiting | Initiation date: Jul 2020 --> Oct 2020
|
|||||||||
lanthanum polystyrene sulfonate powder
/
Liaoning Grand Nuokang Biopharma
New P1/2 trial:
To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder
(clinicaltrials.gov) - Jun 22, 2020
P1/2
, N=48, Not yet recruiting,
Sponsor: Liaoning Grand Nuokang Biopharmaceutical Co., Ltd.